Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

QGEN

Qiagen NV

Dec 26 • 03:40PM ET

45.03

Dollar change -0.03
Percentage change -0.06	%

Healthcare • Diagnostics & Research • Netherlands • NYSE

Peers: TMO DHR ILMN A BIO TECH WAT MTD HOLX BRKR

| Held by: IWR IWD IWS FENI BBH IWB IYH JQUA VONV GSIE

Scroll to Statements

Index	-	P/E	111.56	EPS (ttm)	0.40	Insider Own	0.28%	Shs Outstand	222.26M	Perf Week	2.24%
Market Cap	9.97B	Forward P/E	19.67	EPS next Y	2.29	Insider Trans	0.00%	Shs Float	221.23M	Perf Month	4.13%
Income	92.93M	PEG	17.95	EPS next Q	0.60	Inst Own	79.23%	Short Float	1.69%	Perf Quarter	0.03%
Sales	1.97B	P/S	5.07	EPS this Y	4.13%	Inst Trans	-1.90%	Short Ratio	3.88	Perf Half Y	9.57%
Book/sh	15.88	P/B	2.84	EPS next Y	5.21%	ROA	1.53%	Short Interest	3.73M	Perf Year	3.64%
Cash/sh	6.69	P/C	6.74	EPS next 5Y	6.21%	ROE	2.57%	52W Range	39.03 - 47.44	Perf YTD	3.71%
Dividend Est.	-	P/FCF	21.51	EPS past 5Y	12.66%	ROI	1.90%	52W High	-5.07%	Beta	0.37
Dividend TTM	-	Quick Ratio	1.89	Sales past 5Y	6.29%	Gross Margin	62.63%	52W Low	15.39%	ATR (14)	0.78
Dividend Ex-Date	Jan 30, 2024	Current Ratio	2.17	EPS Y/Y TTM	-72.32%	Oper. Margin	24.00%	RSI (14)	57.27	Volatility	1.87% 1.53%
Employees	5967	Debt/Eq	0.54	Sales Y/Y TTM	0.62%	Profit Margin	4.73%	Recom	1.83	Target Price	51.50
Option/Short	Yes / Yes	LT Debt/Eq	0.39	EPS Q/Q	25.81%	Payout	0.00%	Rel Volume	0.21	Prev Close	45.06
Sales Surprise	2.17%	EPS Surprise	4.91%	Sales Q/Q	5.46%	Earnings	Nov 07 BMO	Avg Volume	961.48K	Price	45.03
SMA20	1.05%	SMA50	3.81%	SMA200	3.54%	Trades		Volume	196,361	Change	-0.06%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Upgrade	Jefferies	Hold → Buy	$42.50 → $54
Oct-17-24	Downgrade	HSBC Securities	Buy → Hold	$49
Jun-27-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$50
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$44
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Dec-07-23	Upgrade	Goldman	Neutral → Buy	$50
Sep-12-23	Initiated	Robert W. Baird	Outperform	$50
May-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-18-22	Initiated	Morgan Stanley	Equal-Weight
Jan-18-22	Upgrade	DZ Bank	Hold → Buy
Oct-15-21	Resumed	Cowen	Market Perform	$55
Oct-14-21	Initiated	Redburn	Buy
Jul-14-21	Downgrade	Kepler	Buy → Hold	$49.53
Jun-03-21	Initiated	Goldman	Neutral	$52
Oct-06-20	Resumed	BofA Securities	Buy	$59
Sep-28-20	Upgrade	Kepler	Hold → Buy
Aug-24-20	Upgrade	Citigroup	Neutral → Buy	$48 → $62
Aug-20-20	Resumed	JP Morgan	Overweight	$60
Aug-17-20	Upgrade	Berenberg	Hold → Buy
Aug-14-20	Upgrade	Exane BNP Paribas	Neutral → Outperform

Show Previous Ratings

Dec-13-24 09:50AM	Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-12-24 04:05PM	QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data (Business Wire)
Dec-06-24 11:31AM	Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-05-24 04:05PM	QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation (Business Wire)
Nov-29-24 09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
05:09AM	Loading…
05:09AM	QIAGEN announces new site in Barcelona for QIAstat-Dx operations (Medical Device Network)
Nov-28-24 10:51AM	QIAGEN introduces new custom tools for microbial analysis (Medical Device Network)
06:00AM	QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing (Business Wire)
Nov-27-24 04:05PM	QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis (GlobeNewswire)
Nov-25-24 09:50AM	Here's Why Qiagen (QGEN) is a Strong Momentum Stock (Zacks)
Nov-12-24 04:05PM	QIAGEN collaborates with McGill University to advance microbiome research (GlobeNewswire)
Nov-11-24 09:15AM	Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock (Zacks)
Nov-09-24 06:35AM	Qiagens Financial Growth and Rising Debt in Q3 2024 (TipRanks)
Nov-08-24 09:40AM	Why Qiagen (QGEN) is a Top Value Stock for the Long-Term (Zacks)
02:19AM	Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
11:19AM	Loading…
Nov-07-24 11:19AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Nov-06-24 08:30PM	Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics (Zacks)
06:40PM	Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates (Zacks)
05:54PM	Qiagen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook (GlobeNewswire)
07:04AM	Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:37AM	Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-04-24 09:16AM	Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
01:30AM	QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics (GlobeNewswire)
Oct-29-24 02:30AM	QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment (GlobeNewswire)
Oct-10-24 04:05PM	QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications (GlobeNewswire)
07:41AM	QIAGEN N.V. to release results for Q3 2024 and hold webcast (GlobeNewswire)
Oct-07-24 04:05PM	Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer (GlobeNewswire)
Oct-01-24 08:45AM	Neogen Announces the Appointment of New Board Member (PR Newswire)
Sep-30-24 04:05PM	QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology (GlobeNewswire)
09:53AM	Loading…
Sep-27-24 09:53AM	Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels (Medical Device Network)
08:32AM	Qiagens QIAstat-Dx respiratory diagnostic wins FDA clearance (Medical Device Network)
Sep-26-24 04:05PM	QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays (GlobeNewswire)
06:12AM	PreAnalytiX introduces urine liquid biopsy solution (Medical Device Network)
Sep-25-24 04:05PM	PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples (GlobeNewswire)
Sep-23-24 04:05PM	QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database (GlobeNewswire)
Sep-18-24 04:05PM	QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform (GlobeNewswire)
Sep-12-24 04:05PM	QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil's national screening programs (GlobeNewswire)
Sep-05-24 09:13AM	Qiagen and Lilly team up for Alzheimers genotype test (Medical Device Network)
Sep-04-24 04:05PM	QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease (GlobeNewswire)
Sep-03-24 05:05PM	QIAGEN N.V. announces conversion price of new net share settled convertible bonds (GlobeNewswire)
11:00AM	QIAGEN N.V. announces successful placement of new net share settled convertible bonds (GlobeNewswire)
02:36AM	QIAGEN N.V. launches non-US offering of net share settled convertible bonds (GlobeNewswire)
Aug-30-24 11:31AM	Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report? (Zacks)
Aug-29-24 06:00AM	Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer (MedTech Dive)
Aug-28-24 04:05PM	QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases (GlobeNewswire)
Aug-22-24 09:50AM	Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-06-24 04:05PM	Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% (GlobeNewswire)
Aug-05-24 09:50AM	Here's Why Qiagen (QGEN) is a Strong Momentum Stock (Zacks)
09:15AM	Unlocking Qiagen (QGEN) International Revenues: Trends, Surprises, and Prospects (Zacks)
Aug-01-24 08:40AM	QIAGEN (QGEN) Q2 Earnings Surpass Estimates, Margins Crash (Zacks)
12:09AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Jul-31-24 08:00PM	Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key Metrics (Zacks)
07:40PM	Qiagen (QGEN) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:37PM	Qiagen: Q2 Earnings Snapshot (Associated Press Finance)
04:06PM	QIAGEN delivers solid performance and exceeds outlook for Q2 2024 (GlobeNewswire)
Jul-24-24 10:01AM	Qiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-18-24 08:53AM	Is QIAGEN (QGEN) a Good Investment Now? Key Factors to Note (Zacks)
Jul-17-24 11:59AM	Qiagen to cut 175 employees, close Michigan PCR test plant (MedTech Dive)
Jul-16-24 12:00PM	Qiagen (QGEN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jul-09-24 09:57AM	QIAGEN (QGEN) Expands in NGS and FIGG With New Partnership (Zacks)
Jul-08-24 04:05PM	QIAGEN to enhance the identification of human remains of Indigenous people and African Americans (GlobeNewswire)
Jul-02-24 09:29AM	QIAGEN N.V. to release results for Q2 2024 and hold webcast (GlobeNewswire)
Jun-30-24 12:38AM	Street calls of the week: Stifel initiates on Tesla; downgrade for Alphabet (Investing.com)
Jun-28-24 08:24AM	QIAGEN (QGEN) Backs New AAP Guidelines Supporting QFT-Plus Test (Zacks)
Jun-27-24 04:05PM	QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children (GlobeNewswire)
Jun-19-24 08:10AM	QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions (Zacks)
Jun-17-24 10:01PM	Analyst Report: Qiagen N.V. (Morningstar Research)
07:35AM	QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays (Zacks)
07:30AM	QIAGEN announces 2028 strategy for solid profitable growth (GlobeNewswire)
Jun-13-24 04:05PM	QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs (GlobeNewswire)
Jun-12-24 04:05PM	QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth (GlobeNewswire)
Jun-11-24 04:05PM	QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance (GlobeNewswire)
Jun-10-24 09:03AM	QIAGEN (QGEN) Unveils dPCR Tool, Enhances GeneGlobe Platform (Zacks)
Jun-06-24 04:05PM	QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period (GlobeNewswire)
Jun-05-24 04:05PM	QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe (GlobeNewswire)
08:20AM	QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu (Zacks)
Jun-03-24 08:23AM	QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit (Zacks)
02:00AM	QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care (GlobeNewswire)
May-31-24 09:39AM	QIAGEN (QGEN) Develops Test for Research and CDx Application (Zacks)
May-30-24 05:55PM	QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications (GlobeNewswire)
May-29-24 04:05PM	QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine (GlobeNewswire)
11:30AM	Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue? (Zacks)
May-16-24 08:45AM	Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now (Zacks)
May-15-24 10:46AM	QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification (Zacks)
May-14-24 04:05PM	QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support (GlobeNewswire)
10:08AM	QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus (Zacks)
May-13-24 12:22PM	QIAGEN (QGEN) to Enhance Forensics With New Partnership (Zacks)
04:18AM	Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test (MT Newswires)
02:00AM	QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results (GlobeNewswire)
May-08-24 09:03AM	Qiagen and FBI partner on DNA quant digital PCR assays (Medical Device Network)
May-07-24 04:05PM	QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics (GlobeNewswire)
May-06-24 08:52AM	International Markets and Qiagen (QGEN): A Deep Dive for Investors (Zacks)
May-02-24 04:05PM	QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications (GlobeNewswire)
May-01-24 12:49PM	Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 12:26PM	QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand (Zacks)
11:37AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Apr-29-24 08:54PM	QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings (Zacks)
05:25PM	Qiagen (QGEN) Surpasses Q1 Earnings and Revenue Estimates (Zacks)

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sackers Roland	Officer	Sep 11 '24	Proposed Sale	46.00	25,000	1,150,000		Sep 11 06:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QGEN

Qiagen NV

Upgrade your FINVIZ experience